Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
February 3, 2023 CD as API / CD derivatives / Pharma applications

Mannose-modified methyl-β-cyclodextrin suppresses tumor growth

Methylated β-cyclodextrin (MeβCD) can extract cholesterol from lipid rafts and induce apoptosis in cancer cells by inhibiting activation of the

Continue reading

February 1, 2023 CD derivatives / Drug delivery / Pharma applications

Coatings of Cyclodextrin/Citric-Acid Biopolymer as Drug Delivery Systems: A Review

In the early 2000s, a method for cross-linking cyclodextrins (CDs) with citric acid (CTR) was developed. This method was nontoxic,

Continue reading

January 31, 2023 Food / Non-pharma applications

α-CD as laxative for pets and CD as litter deodorant

In present post, two Japanese products for pet care are discussed. The product characteristics quoted here reflect the information claimed

Continue reading

January 20, 2023 Drug delivery / Pharma applications

Cyclodextrin Metal-Organic Framework as a Broad-Spectrum Potential Delivery Vehicle for the Gasotransmitters

The important role of gasotransmitters in physiology and pathophysiology suggest employing gasotransmitters for biomedical treatment. Unfortunately, the difficulty in storage

Continue reading

books in black wooden book shelf
January 20, 2023 Drug delivery / E-ducation / Pharma applications

Published compilation of the list of approved cyclodextrin-containing drug products

A group of researchers at CycloLab continuously follow the new drug composition approvals especially those benefiting the use of cyclodextrins.

Continue reading

January 19, 2023 Events

Conference Proceedings of ICS-2022 in a Special issue of IJMS published

The Special Issue, which has been published in open access journal International Journal of Molecular Sciences (ISSN 1422-0067): “Recent Insights

Continue reading

January 18, 2023 CD derivatives / Drug delivery / Pharma applications

New US patent for SBECD purification by CycloLab

The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was

Continue reading

January 17, 2023 Analysis / CD derivatives

A novel polymeric nanocomposite based on TiO2 NPs containing β-cyclodextrin membrane for ultratrace naked-eye detection of Pb and Cd ions

A unique, selective, and sensitive colorimetric nanosensor for the naked-eye detection and adsorption of Pb(II) and Cd(II) in aqueous media

Continue reading

January 16, 2023 Non-pharma applications / Pharma applications

New book: Cyclodextrins – new Perspectives

Two chapters of a book under preparation were found on the internet (IntechOpen): Ludmila Aricov, Anca Ruxandra Leontieș, Iulia Matei

Continue reading

January 13, 2023 Drug delivery / Events / Pharma applications

Symposium of Drug Delivery Systems

The 10th Annual International Symposium of Drug Delivery Systems (SDDS-2023) postponed from the last year is going to be held

Continue reading

January 12, 2023 Drug delivery / Pharma applications

Sustainable γ-cyclodextrin frameworks containing ultra-fine silver nanoparticles with enhanced antimicrobial efficacy

Cyclodextrin metal-organic frameworks (CD-MOF) are a class of biocompatible MOFs with a great potential in drug delivery applications. Original CD-MOF

Continue reading

January 11, 2023 Environmental / Non-pharma applications

β-cyclodextrin functionalized gold nanoparticles as an effective nanocatalyst for reducing toxic nitroaromatics

An effective reduction of the organic pollutants, the nitroaromatics, was demonstrated via green sustainable chemistry using high efficacy of the

Continue reading

January 10, 2023 Drug delivery / Pharma applications

Transdermal delivery by smart tattoo

Tattoos are already used in the clinic to mark where doctors will apply radiation treatments, to correct skin discoloration, to mark

Continue reading

Posts navigation

«Previous Posts 1 2 3 4 … 110 Next Posts»

Recent Posts

  • Mannose-modified methyl-β-cyclodextrin suppresses tumor growth
  • Cyclodextrin Based Polymeric Nanobeads
  • Coatings of Cyclodextrin/Citric-Acid Biopolymer as Drug Delivery Systems: A Review
  • α-CD as laxative for pets and CD as litter deodorant
  • 7th European Cyclodextrin Conference

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (200)
  • CD derivatives (254)
  • Cosmetics and toilettry (21)
  • Drug delivery (418)
  • E-ducation (54)
  • Environmental (76)
  • Events (158)
  • Food (121)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (13)
  • Non-pharma applications (210)
  • Other industrial use (58)
  • Pharma applications (680)
  • Supramolecular systems (25)
  • Uncategorized (41)

Top Posts

  • α-CD as laxative for pets and CD as litter deodorant
  • Cyclodextrin Based Polymeric Nanobeads
  • Lanosterol eye drops for cataract treatment
  • Coatings of Cyclodextrin/Citric-Acid Biopolymer as Drug Delivery Systems: A Review
  • International Symposium of Drug Delivery Systems (SDDS-2022)
  • 7th European Cyclodextrin Conference
  • Mannose-modified methyl-β-cyclodextrin suppresses tumor growth
  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • How air fresheners work?
  • GRAS status of CD derivatives

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 522 other subscribers
 

Loading Comments...